4//SEC Filing
Mpofu Shephard 4
Accession 0001962918-25-000060
CIK 0001962918other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:08 PM ET
Size
14.1 KB
Accession
0001962918-25-000060
Insider Transaction Report
Form 4
ACELYRIN, Inc.SLRN
Mpofu Shephard
Chief Medical Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2025-05-21−118,858→ 0 totalExercise: $10.17Exp: 2033-09-28→ Common Stock (118,858 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-05-21−142,586→ 0 totalExercise: $7.68Exp: 2034-01-08→ Common Stock (142,586 underlying) - Disposition to Issuer
Common Stock
2025-05-21−121,789→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2025-05-21−328,860→ 0 totalExercise: $4.22Exp: 2034-05-22→ Common Stock (328,860 underlying)
Footnotes (6)
- [F1]On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the "Merger Agreement") with Alumis, Inc., a Delaware corporation ("Parent"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the "Exchange Ratio") shares of voting common stock of Parent, par value $0.0001 per share ("Parent Common Stock"), and cash in lieu of any fractional shares.
- [F2](Continued from Footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unvested restricted stock unit ("RSU") immediately prior to the Effective Time was assumed by Parent and converted into an RSU award with respect to a number of shares of Parent Common Stock equal to (i) the total number of shares subject to the RSU immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share. At the Effective Time, each outstanding and vested RSU immediately prior the Effective Time, including any RSU that became vested as a result of the Merger, was cancelled and converted into the right to receive the number of shares of Parent Common Stock equal to (i) the total number of shares subject to the RSU immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share.
- [F3]1/4 of the shares subject to the option vest on May 23, 2025, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
- [F4]Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent.
- [F5]1/4 of the shares subject to the option vested on January 9, 2025, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
- [F6]1/4 of the shares subject to the option vested on September 25, 2024 and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Documents
Issuer
ACELYRIN, Inc.
CIK 0001962918
Entity typeother
Related Parties
1- filerCIK 0002023809
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:08 PM ET
- Size
- 14.1 KB